• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
D-dimer and Beyond: Harnessing the Potential of New Coagulation Indicators in COVID-19 Management.D-二聚体及其他：挖掘新型凝血指标在COVID-19管理中的潜力
Intern Med. 2023 Oct 15;62(20):2929-2930. doi: 10.2169/internalmedicine.2355-23. Epub 2023 Aug 2.
2
Coagulopathy in COVID-19.新型冠状病毒疾病中的凝血功能障碍。
J Thromb Haemost. 2020 Sep;18(9):2103-2109. doi: 10.1111/jth.14975. Epub 2020 Jul 21.
3
Major coagulation disorders and parameters in COVID-19 patients.COVID-19 患者的主要凝血障碍和参数。
Eur J Med Res. 2022 Feb 15;27(1):25. doi: 10.1186/s40001-022-00655-6.
4
Inflammation/coagulopathy/fibrinolysis: Dynamic indicators of COVID-19 progression in patients with moderate COVID-19 in Wenzhou, China.炎症/凝血功能障碍/纤维蛋白溶解：中国温州中度 COVID-19 患者病情进展的动态指标。
Clin Immunol. 2021 Nov;232:108852. doi: 10.1016/j.clim.2021.108852. Epub 2021 Sep 11.
5
Complement activation and coagulopathy - an ominous duo in COVID19.补体激活与凝血障碍——COVID-19 中的凶险组合。
Expert Rev Hematol. 2021 Feb;14(2):155-173. doi: 10.1080/17474086.2021.1875813. Epub 2021 Jan 22.
6
Use of fibrin monomer and D-Dimer in assessing overt and nonovert disseminated intravascular coagulation.纤维蛋白单体和 D-二聚体在显性和非显性弥漫性血管内凝血评估中的应用。
Blood Coagul Fibrinolysis. 2021 Jun 1;32(4):248-252. doi: 10.1097/MBC.0000000000001025.
7
D-Dimer Testing: Laboratory Aspects and Current Issues.D-二聚体检测：实验室相关方面及当前问题
Methods Mol Biol. 2017;1646:91-104. doi: 10.1007/978-1-4939-7196-1_7.
8
COVID-19-associated coagulopathy and disseminated intravascular coagulation.COVID-19 相关凝血功能障碍和弥散性血管内凝血。
Int J Hematol. 2021 Jan;113(1):45-57. doi: 10.1007/s12185-020-03029-y. Epub 2020 Nov 7.
9
A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen.活化凝血和/或纤维蛋白溶解标志物检测方法的比较评估：凝血酶 - 抗凝血酶复合物、D - 二聚体和纤维蛋白原/纤维蛋白片段E抗原
Br J Haematol. 1990 Apr;74(4):471-9. doi: 10.1111/j.1365-2141.1990.tb06337.x.
10
Coagulopathy and Traumatic Brain Injury: Overview of New Diagnostic and Therapeutic Strategies.凝血障碍与创伤性脑损伤：新的诊断与治疗策略概述。
Neurol Med Chir (Tokyo). 2022 Jun 15;62(6):261-269. doi: 10.2176/jns-nmc.2022-0018. Epub 2022 Apr 22.

本文引用的文献

1
Role of Fibrin Monomer Complex in Coronavirus Disease 2019 for Venous Thromboembolism and the Prognosis.纤维蛋白单体复合物在 COVID-19 相关静脉血栓栓塞症及预后中的作用。
Intern Med. 2023 Oct 15;62(20):2941-2948. doi: 10.2169/internalmedicine.1322-22. Epub 2023 Aug 2.
2
ISTH guidelines for antithrombotic treatment in COVID-19.ISTH 新冠肺炎患者抗血栓治疗指南。
J Thromb Haemost. 2022 Oct;20(10):2214-2225. doi: 10.1111/jth.15808. Epub 2022 Jul 29.
3
Assessment of thromboembolism risk in COVID-19 patients with cardiovascular disease risk factors: Analysis of a Japanese Nationwide Registry.评估伴有心血管疾病危险因素的 COVID-19 患者的血栓栓塞风险：日本全国注册研究分析。
Thromb Res. 2022 Aug;216:90-96. doi: 10.1016/j.thromres.2022.06.007. Epub 2022 Jun 24.
4
Randomized trials of therapeutic heparin for COVID-19: A meta-analysis.COVID-19治疗性肝素的随机试验：一项荟萃分析。
Res Pract Thromb Haemost. 2021 Dec 17;5(8):e12638. doi: 10.1002/rth2.12638. eCollection 2021 Dec.
5
Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial.COVID-19 住院高危患者中治疗剂量肝素与标准预防剂量或中剂量肝素预防血栓的疗效和安全性：HEP-COVID 随机临床试验。
JAMA Intern Med. 2021 Dec 1;181(12):1612-1620. doi: 10.1001/jamainternmed.2021.6203.
6
Diagnostic Value of D-Dimer in COVID-19: A Meta-Analysis and Meta-Regression.D-二聚体在 COVID-19 中的诊断价值：荟萃分析和荟萃回归。
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211010976. doi: 10.1177/10760296211010976.
7
Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019: A Systematic Review and Meta-analysis.COVID-19 住院患者静脉血栓栓塞症和出血的发生率：系统评价和荟萃分析。
Chest. 2021 Mar;159(3):1182-1196. doi: 10.1016/j.chest.2020.11.005. Epub 2020 Nov 17.
8
Thrombosis risk associated with COVID-19 infection. A scoping review.与 COVID-19 感染相关的血栓形成风险。范围综述。
Thromb Res. 2020 Aug;192:152-160. doi: 10.1016/j.thromres.2020.05.039. Epub 2020 May 27.
9
Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels.COVID-19 肺炎伴 D-二聚体升高患者无症状性深静脉血栓形成的发生率。
Thromb Res. 2020 Aug;192:23-26. doi: 10.1016/j.thromres.2020.05.018. Epub 2020 May 13.
10
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study.COVID-19 患者的尸检结果与静脉血栓栓塞：一项前瞻性队列研究。
Ann Intern Med. 2020 Aug 18;173(4):268-277. doi: 10.7326/M20-2003. Epub 2020 May 6.

D-dimer and Beyond: Harnessing the Potential of New Coagulation Indicators in COVID-19 Management.

作者信息

Shibahashi Eiji, Jujo Kentaro

机构信息

Department of Cardiology, Tokyo Women's Medical University, Japan.

Department of Cardiology, Saitama Medical University, Saitama Medical Center, Japan.

出版信息

Intern Med. 2023 Oct 15;62(20):2929-2930. doi: 10.2169/internalmedicine.2355-23. Epub 2023 Aug 2.

DOI:10.2169/internalmedicine.2355-23
PMID:37532543
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10641190/
Abstract
摘要